1Boyle P, Levin B. World Cancer Report 2008 [ M ]. Lyon : In- ternational Agency for Research on Cancer( IARC ) , 2008: 14 - 15.
2Kibria G, Hatakeyama H, Harashima H. Cancer multidrug resistance: mechanisms involved and strategies for circum- vention using a drug delivery system[ J]. Arch Pharm Res, 2014,37(1) :4 -15.
3Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants[ J ]. Bio- chem Biophys Acta, 1976,455 ( 1 ) 152 - 162.
4Andorfer P, Rotheneder H. Regulation of the MDR1 promot- er by E2Fland EAPP[J]. FEBS Lett,2013,587(10) :1504 - 1509.
5Amiri - Kordestani L, Basseville A, Kurdziel K, et al. Targe- ting MDR in breast and lung cancer: discriminating its po- tential importance from the failure of drug resistance reversal studies [ J ]. Drug Resist Updat ,2012,15 ( 1 - 2 ) :50 - 61.
6Mao QC, Jashvant D. Role of the breast cancer resistance protein( BCRP./ABCG2 ) in drug transport - an update [ J ]. The AAPS Journal,2015,17 ( 1 ) : 65 - 82.
7Azab F,Vali S,Abraham J,et al. PI3KCA plays a major role in multiple myeloma and its inhibition with BYLT19 decrea- ses proliferation, synergizes with other therapies and over- comes stroma - induced resistance [ J ]. Bfit J Haematol, 2014,165( 1 ) :89 - 101.
8Kanwar JS,Kamalapuram R, Kanwar RK. Targeting survivin in cancer: The cell - signalling perspective [ J]. Drug Dis- covery Today,2011,16 ( 11 - 12) :485 - 494.
9Vinod BS,Maliekal Tl', Anto RJ. Phytochemicals as chemo- sensitizers: from molecular mechanism to clinical signifi- cance [ J ]. Antioxid Redox Signal, 2013,18 ( 11 ) : 1307 1348.
10O'Donovan TR, O'Sullivan GC, McKenna SL, Induction of autophagy by drug resistant esophageal cancer eells pro- motes their survival and recovery following treatment with chemotherapeutics [ J ]. Autophagy, 2011,7 ( 5 ) : 509 - 524.
